Moderna (MRNA) came out with a quarterly loss of $1.18 per share versus the Zacks Consensus Estimate of a loss of $3.02. This compares to a loss of $2.52 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +60.93%. A quarter ago, it was expected that this biotechnology company would post a loss of $2.6 per share when it actually produced a loss of $2.11, delivering a surprise of +18.85%.Over the last four quarters, the company has ...